Search

everythinglearnresearchcommunity

for

Search:↓

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

The method accurately measures testosterone metabolites with high sensitivity and low environmental impact.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

The procedure accurately measures 5-alpha-dihydrotestosterone in blood, useful for standard tests.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

MK-5108 is safe and shows potential against tumors, especially alone.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Tofacitinib treatment is used for teenagers with alopecia areata.

The hydrogel quickly stops bleeding and helps heal infected wounds.

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Baricitinib was effective in treating both early and late onset alopecia areata.

Topical tacalcitol can treat psoriasis by acting directly on skin cells.

TRM21 helps control flavonoid production and root hair growth in Arabidopsis thaliana.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Recombinant human TSG-6 speeds up wound healing in diabetic mice.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

The PCR technique can identify genetic differences in a wool-related gene among different sheep breeds, which may help improve wool and pelt quality.